Pharmafile Logo
Pharmafocus logo
Advanced Search
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 2, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, GSK, ITH Pharma, J&J, JJ, NICE, Sanofi, Trump, top 10

Deals dominated the headlines this week as both Sanofi and AstraZeneca made billion dollar agreements. Meanwhile, the FDA gave magic …

News
alk_logo_32_nodith

Committee advises against FDA approval of Alkermes’ novel depression drug

November 2, 2018
Medical Communications, Sales and Marketing Alkermes, FDA, depression, pharma

Alkermes has been knocked back with the disappointing, though not entirely unexpected, news that the FDA-appointed Psychopharmacologic Drugs Advisory Committee …

News

Novo Nordisk cuts 1300 jobs in the midst of Trump’s pricing pressures and depreciation of US dollar

November 2, 2018
Medical Communications Jobs, Novo Nordisk, Trump, pressure, pricing, revenue

Danish multinational Novo Nordisk has said that they will have cut 1,300 employees by the end of 2018. The decision …

News
gwpharma

GW Pharma’s Epidiolex becomes first cannabis-based medicine to be made available in United States

November 2, 2018
Medical Communications Epidiolex, GW Pharma, Medical marijuana, cannabidiol, cannabis

GW Pharma’s Epidiolex has become the first plant-derived, cannabis-based medicine to be made available on prescription in all 50 US …

News

Galectin-3: The protein paving new treatment avenues

November 1, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Galectin-3, Galectins, breast cancer, diabetes, heart disease, pharma

Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund University, …

Feature

Sanofi teams up with Denali in $1.125bn neurological and inflammatory development deal

November 1, 2018
Research and Development, Sales and Marketing Denali Therapeutics, Sanofi, pharma

Sanofi has sealed the deal with Denali Therapeutics to leverage the latter’s small molecule candidates in the development of new …

News
medicinal_cannabis_uk_review

Medical Marijuana to be legalised in Thailand and Malaysia as drug becomes available on prescription in UK

November 1, 2018
Business Services, Medical Communications Medical marijuana, UK, cannabis, malaysia, thailand

Thailand’s public health ministry is working to make medical marijuana legal by next month. The shift is expected to come …

News
gehrynovartis

Novartis cuts 20% of research projects

November 1, 2018
Business Services, Research and Development Business, Novartis, gene therapy, infectious diseases, research

Swiss multinational Novartis has cut a fifth of its research projects, as it abandons 90 of its 430 drug development …

News
merckincweb2

MSD’s Keytruda/chemo combo scores first-line FDA approval in NSC lung cancer

November 1, 2018
Sales and Marketing Cancer, MSD, NSCLC, keytruda, lung cancer, pharma

MSD’s blockbuster anti-PD-1 immunotherapy has secured another FDA approval, it has emerged, in combination with carboplatin and either paclitaxel or …

News

Parents should ignore anti-vaccine “social media fake news”, according to England’s medical chief

November 1, 2018
Medical Communications England, MMR, Vaccine, anti-vaccine, fake news

England’s Chief Medical Officer Dame Sally Davies has said that the MMR vaccine is “a safe vaccination” as she encouraged …

News
shutterstock_92671375

Metropolitan Police charge ITH Pharma over IV feed-linked baby deaths

October 31, 2018
Research and Development ITH Pharma, Metropolitan Police, NHS, pharma

An investigation into the deaths and illnesses of several babies at a number of UK hospitals has prompted London’s Metropolitan …

News
astrazeneca_plaque

AstraZeneca flogs two drug licenses in $922 million deal

October 31, 2018
Research and Development, Sales and Marketing AstraZeneca, pharma

AstraZeneca has signed a deal with Grünenthal worth up to $922 million in which the latter will acquire the regional …

News
eye2

Common diabetes drug can protect against age-related macular degeneration, research shows

October 31, 2018
Research and Development age-related macular degeneration, diabetes, eye, metformin, pharma

A Taiwanese research team has demonstrated a link between the use of the common diabetes medication metformin and significantly lower …

News

J&J’s Invokana becomes first FDA-approved oral diabetes drug to reduce cardiovascular event risk

October 31, 2018
Research and Development, Sales and Marketing FDA, J&J, JJ, invokana, pharma

The FDA has given the go-ahead for Johnson & Johnson’s drug Invokana (canagliflozin) for use in the risk reduction of …

News

NICE turns down Sanofi’s Caprelsa for rare thyroid cancer

October 31, 2018
Research and Development, Sales and Marketing Cancer, Caprelsa, NHS, NICE, Sanofi, UK, medullary thyroid cancer, pharma

NICE has announced its recommendation to reject Sanofi’s Caprelsa (vandetanib) for use on the NHS in the treatment of medullary …

News

Half of kidney cancer patients initially misdiagnosed

October 30, 2018
Manufacturing and Production Cancer, Kidney cancer, NHS, UK, diagnosis

Half of kidney cancer patients are initially misdiagnosed, according to data from Kidney Cancer UK’s patient survey. Despite being the …

News
shutterstock_339308225

UK MPs call for greater action on clinical transparency and trial reporting

October 30, 2018
Manufacturing and Production, Research and Development UK, c linical transparency, clinical trials, pharma, transparency

The UK’s House of Commons Science and Technology Committee has argued in a new report that the failure of clinical …

News
gsk_china_8

GSK announces results of three year trial into long-lasting HIV injection

October 30, 2018
Manufacturing and Production GSK, HIV, drugs, injection, medication

GlaxoSmithKline have announced the results of a three year investigation into a long acting, injectable, two-drug HIV regimen at the …

News

NHS to receive additional £20.5 billion each year from 2018 Budget

October 30, 2018
Manufacturing and Production Budget, Conservatives, Labour, NHS, mental health, politics

The NHS will receive an additional £20.5 billion a year until 2023-24, according to the Budget released yesterday. The confirmation …

News
slimming-2728331_960_720

Effective preventative therapies for type 2 diabetes are underused, new research argues

October 30, 2018
Manufacturing and Production, Research and Development, Sales and Marketing diabetes, obesity, pharma, prediabetes, type 2 diabetes

New research has warned that interventions which can effectively delay or prevent the development of type 2 diabetes are not …

News
The Gateway to Local Adoption Series

Latest content

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026